[GLOS03_code]

The Qualified Research Expense (QRE): Context, Compliance, and Strategic Optimization within U.S. R&D Tax Law

Executive Summary: The Critical Role of QREs in Federal Tax Strategy

Qualified Research Expenses (QREs) represent the foundational cost component upon which the federal Credit for Increasing Research Activities, codified under Internal Revenue Code (IRC) Section 41, is calculated. These expenses—which comprise specific categories of employee wages, consumed supplies, and contract research costs—are expenditures incurred by a taxpayer in connection with qualified research activities that meet the stringent IRS Four-Part Test.1 QREs serve as a direct and measurable metric for quantifying a company’s investment in domestic innovation, enabling taxpayers to reduce their federal income tax liability. For qualified small businesses (QSBs), the value generated by QREs can be elected as an offset against payroll taxes, thereby providing immediate cash flow relief to pre-revenue or early-stage enterprises and incentivizing sustained investment in technological advancement.3 This dual role, defining the permissible scope of research costs and simultaneously driving the calculation of a potentially significant tax benefit, underscores the absolute necessity of precise QRE identification and rigorous contemporaneous documentation.

The strategic importance of QREs extends beyond mere calculation; proper identification and allocation are essential for successful compliance and maximizing the credit value. QREs fall into three primary statutory categories: Wages paid for qualified services performed by employees (such as engaging in, directly supervising, or directly supporting qualified research), Supplies (tangible materials consumed during experimentation, excluding depreciable assets), and Contract Research Expenses (payments to unrelated third parties, generally limited to 65% of the expense).2 To illustrate this application, consider a technology company developing new cloud-based software that requires the design of scalable REST APIs because existing data exchange protocols present a demonstrable technical uncertainty regarding performance and reliability.8 The qualified wages paid to the in-house senior developers actively coding, testing, and debugging these new protocols, alongside the cost of temporary cloud servers and testing materials (supplies) consumed solely for conducting non-routine performance testing and systematic experimentation, would constitute QREs, provided the underlying development activity satisfies all components of the mandatory Four-Part Test.1 Conversely, general administrative wages, capitalized computer equipment, or costs for research conducted outside the United States would be explicitly excluded.2

I. Statutory and Regulatory Foundation of Qualified Research Expenses (QREs)

1.1. Legal Basis and Trade or Business Requirement

The eligibility for the Credit for Increasing Research Activities under IRC Section 41 is entirely contingent upon the taxpayer’s ability to substantiate the existence and amount of Qualified Research Expenses. The statute mandates that the credit is determined by the sum of in-house research expenses and contract research expenses.9 These expenses must satisfy a fundamental requirement: they must be “paid or incurred by the taxpayer in carrying on a trade or business of the taxpayer”.10 This requirement ensures that the research activities are connected to a legitimate commercial endeavor and shares the same meaning established in other relevant sections of the Internal Revenue Code.

For the vast majority of companies, demonstrating that the research is conducted “in carrying on a trade or business” is straightforward. However, a critical statutory relief provision exists for certain startup ventures concerning in-house research expenses. For these qualifying businesses, the trade or business requirement is disregarded if the principal purpose of the expenditures is to use the results of the research in the active conduct of a future trade or business.11 This provision is instrumental, particularly for smaller, pre-revenue companies seeking to utilize the Qualified Small Business (QSB) payroll tax offset, which allows them to monetize the credit immediately against employer Social Security taxes, rather than waiting for future income tax liability.3

1.2. The Complex Interplay with IRC Section 174 (R&E Costs)

A thorough understanding of QREs requires recognizing the inherent tension between two distinct sections of the Internal Revenue Code: Section 41, which governs the credit (based on QREs), and Section 174, which governs the timing of the deduction for Research and Experimental (R&E) expenditures.

Prior to 2022, R&E expenditures were generally deductible in the year incurred. However, the Tax Cuts and Jobs Act (TCJA) introduced a substantial change for tax years beginning after December 31, 2021, mandating that all R&E expenditures (which largely include QREs) must be capitalized and amortized over five years for domestic research and 15 years for foreign research.12 This capitalization requirement created a counter-intuitive cash flow paradox for many taxpayers. The core analysis shows that while the $\S$41 credit provided a dollar-for-dollar reduction in tax liability, the simultaneous mandatory capitalization under $\S$174 significantly increased current taxable income by deferring the deduction.12 For many businesses, particularly those with modest profits or aggressive R&D spending, the immediate tax cost associated with income inflation from deduction deferral could potentially outweigh the benefit derived from the $\S$41 credit. This relationship elevated the importance of complex financial modeling to optimize the net tax position.

Looking forward, new legislation (referred to as P.L. 119-21, or the One Big Beautiful Bill Act, restoring $\S$174A) is anticipated to restore the option for immediate expensing of domestic R&E costs for tax years beginning after 2024.12 This legislative change will significantly alleviate the compliance burden and the cash flow strain imposed during the 2022–2024 period. Nevertheless, taxpayers must develop a strategic approach concerning previously capitalized R&E costs incurred during those years. They will need to model whether it is more beneficial to continue amortizing those costs over their remaining five-year recovery period, which is the default path, or elect to accelerate the recovery if transition rules permit, to capture a larger deduction in 2025.12 The integration of $\S$41 QRE planning with $\S$174 cost management is therefore a crucial annual requirement for effective tax strategy.

II. Definitional Scope: The Three Pillars of Qualified Research Expenses

The Internal Revenue Code explicitly defines QREs as the sum of in-house research expenses and contract research expenses.7 Strict statutory definitions apply to each of the three component categories to prevent the inclusion of general business or administrative costs.5

2.1. Qualified Wages

Qualified wages constitute the largest QRE component for most research-intensive companies. These are wages paid or incurred to an employee for performing qualified services.2 Qualified services are narrowly defined as services consisting of either (i) actively engaging in qualified research, or (ii) directly supervising or directly supporting qualified research.2 An example of direct support would be a laboratory technician responsible for calibrating and maintaining specialized machinery used solely in the process of experimentation.

A crucial compliance rule governing employee wages is the Substantially All Rule. If 80% or more of an employee’s services during the year constitute qualified services, then the full 100% of that employee’s wages may be included as a QRE. If the employee spends less than 80% of their time on qualified activities, only the allocated portion of wages corresponding to qualified services is eligible.2 General and administrative (G&A) costs are strictly excluded from QREs.5 Consequently, for employees with mixed roles—such as a chief technology officer who splits time between technical development and general corporate management—precise, defensible time tracking and allocation are essential. Any unsubstantiated or arbitrary allocation is a common area of IRS challenge, as the taxpayer must demonstrate a clear and proven nexus between the time expended and the qualified research activity, validating that the time spent was not related to excluded G&A functions.

2.2. Qualified Supplies

Qualified supplies are defined as the cost of any tangible property that is used or consumed in the conduct of qualified research.2 A paramount constraint is the exclusion of land, improvements to land, and any property that is subject to depreciation.2 This non-depreciable requirement is critical for compliance.

Supplies must be entirely consumed during the research process.5 For example, raw materials used solely to fabricate and test prototypes are eligible QREs, provided those prototypes are subsequently destroyed or consumed during testing. If an item, such as a piece of specialized testing equipment or a large-scale prototype, has a useful life extending beyond the taxable year or is later used in commercial production, it becomes a capitalized R&E cost under $\S$174 but is explicitly disqualified as a $\S$41 QRE supply.2 This strict segregation requires meticulous financial tracking to distinguish between short-lived, consumed materials (QREs) and long-lived assets (capital expenditures) used in R&D. The underlying principle is to prevent the taxpayer from benefiting from both the immediate tax credit and the long-term deduction (depreciation or amortization) on the same capital investment.

2.3. Contract Research Expenses (CREs)

Contract Research Expenses are amounts paid by the taxpayer to an unrelated third party for the performance of qualified research.7 Statutorily, only 65% of the total cost paid or incurred for contract research qualifies as a QRE. This percentage increases to 75% if the payment is made to a qualified research consortium meeting specific requirements (e.g., being a 501(c)(3) or 501(c)(6) organization primarily organized to conduct scientific research).11

The most frequent audit risk associated with CREs is the “Funded Research” Exclusion. Research is explicitly non-qualifying if it is deemed to be “funded” by another person, government entity, or private third party.14 Determining if research is funded involves a rigorous, two-pronged analysis:

1. Economic Risk: The taxpayer claiming the credit must bear the economic risk related to the technical success or failure of the research. If the contract guarantees a specific result or if the contractor bears the financial burden of technical failure, the research is likely funded and ineligible.
2. Substantial Rights: The taxpayer must retain substantial rights to the results of the research.14 Recent guidance issued by the IRS emphasizes that this requirement links the $\S$41 R&D credit rules to the broader $\S$174 requirements concerning the right to exploit the research results, demanding clear intellectual property (IP) ownership by the taxpayer.14

Contract research claims are consistently scrutinized during examinations. Therefore, the contractual language must unambiguously confirm that the taxpayer assumes the financial risk of technical uncertainty and reserves clear ownership of the resulting intellectual property. Standard fixed-fee or “work-for-hire” service agreements that shift risk away from the taxpayer often fail this complex statutory test.

The three primary categories of QREs and their compliance requirements are summarized below.

QRE Category Requirements and Statutory Limitations

III. Qualifying Activities: The Mandate of the Four-Part Test

A cost, regardless of its classification as a wage, supply, or contract expense, is only a QRE if it is incurred in connection with an activity that meets the rigorous IRS Four-Part Test, which validates the technical legitimacy of the underlying research.1 This mandate fundamentally establishes that the dollar amount (the expense) is only valid if the underlying activity (the technical justification) meets these statutory requirements.

3.1. The Four Test Components

The Four-Part Test imposes a high bar, requiring systematic evidence that the activities were non-routine and faced genuine technological challenges:

1. Section 174/Business Component Test: The activity must be intended to develop or improve the functionality, performance, reliability, or quality of a business component, which includes a product, process, technique, formula, invention, or software.1
2. Technological Uncertainty Test: The taxpayer must demonstrate that, at the outset of the research, there was significant technical uncertainty regarding the appropriate design, method, approach, or ultimate capability of the resulting business component.1
3. Process of Experimentation Test: The activity must involve a systematic process—such as modeling, simulation, or trial and error—designed specifically to evaluate alternatives and resolve the identified technological uncertainty.1 This process differentiates true research from routine development or problem-solving.
4. Technological in Nature Test: The underlying uncertainty being resolved must be based on principles of hard science, including engineering, computer science, chemistry, or physics.1

The failure of any single part of this Four-Part Test invalidates all associated QREs for that project. This interdependence necessitates that the technical and financial documentation are inextricably linked. The compliance team’s highest priority must be to ensure that R&D and engineering staff provide continuous, detailed records proving the technical necessity and systematic nature of the work, thereby linking the expenditure (the QRE) directly to the resolution of a justified technological uncertainty.15

3.2. Explicit Exclusions Under IRC §41(d)(4)

IRC Section 41 explicitly excludes certain activities, even if they involve technical personnel or significant expenditures. These exclusions define the boundaries between qualified innovation and routine business operations:

• Research After Commercial Production: Activities related to routine maintenance, debugging, or quality control after the business component has been released for commercial use do not qualify.9
• Adaptation or Duplication: Research aimed at adapting an existing component to fit a specific customer’s needs or reproducing an existing business component from publicly available information, plans, or physical examination is excluded.9
• Non-Technological Activities: This covers efficiency surveys, market research, routine data collection, management studies, and research related to foreign operations.9 These activities are typically rejected because they do not address technological uncertainty in a systematic way rooted in the hard sciences.
• Funded Research: As detailed previously, research funded by a third party, where the taxpayer lacks economic risk or substantial rights to the results, is excluded.14

IV. Calculation Methodologies and Maximization Strategies

The quantity of validated QREs serves as the input for calculating the tax credit, but the resulting benefit is highly dependent on the calculation methodology chosen. Taxpayers must choose between the Regular Credit Method and the Alternative Simplified Credit (ASC) Method.

4.1. The Regular Credit Method

The Regular Credit Method calculates the credit as 20% of the excess of the current year’s QREs over the defined “base amount”.3 The complexity of this method lies in defining the base amount. It is determined by multiplying the taxpayer’s fixed-base percentage (a historical ratio of QREs to gross receipts established during specific past years) by the average annual gross receipts for the four taxable years preceding the credit year.11 This method is generally most advantageous for mature companies with a history of stable research investment or where the fixed-base percentage is favorable, allowing the highest potential credit rate of 20%.

4.2. The Alternative Simplified Credit (ASC) Method

The Alternative Simplified Credit (ASC) Method offers a more streamlined calculation. Under ASC, the credit is equal to 14% of the current year’s QREs that exceed 50% of the average QREs from the three immediately preceding tax years.3 Taxpayers have the critical strategic advantage of electing to use the ASC method annually.3

The ASC often proves more beneficial for rapidly growing companies or those with a limited history of research activities, as its base amount calculation (50% of the three-year average) is inherently less punitive than the potentially higher historical fixed-base percentage derived from the Regular Credit Method.3 The ability to switch between calculation methods annually necessitates proactive and thorough modeling of both approaches to determine the optimal strategy that maximizes the current year’s credit value based on historical spending patterns and gross receipts.

4.3. The Qualified Small Business (QSB) Payroll Tax Election

For eligible Qualified Small Businesses (QSBs)—generally defined as companies with less than $\$5$ million in gross receipts for the current tax year and no gross receipts for any of the five preceding tax years—a crucial alternative use of the credit exists.4 These startups and early-stage firms may elect to apply a portion of the calculated credit against the employer portion of their Social Security taxes.3 This provision provides an immediate cash flow benefit to businesses that, lacking income tax liability, would otherwise be unable to utilize the credit until future profitable years.8 To utilize this election, the taxpayer must complete Section D of IRS Form 6765, Credit for Increasing Research Activities.1

V. Next Steps: Strategic Compliance, Documentation, and Audit Defense

To ensure the effective and full use of Qualified Research Expenses, tax compliance must evolve from a periodic claim preparation exercise to a continuous, integrated management process supported by robust systems and cross-departmental communication. The primary objective is establishing an active audit defense strategy concurrent with the research activities themselves.

5.1. Implementing Contemporaneous Documentation Protocols

The heightened scrutiny by the IRS, demanding detailed project descriptions and contemporaneous records, makes formalized documentation protocols mandatory for establishing claim validity.16 The real risk in the current compliance environment is not merely claiming the credit, but claiming it without a clear, documented road map that can withstand a comprehensive examination.16

Action Item 1: Technical Activity Records. Taxpayers must implement a systematic process for recording project objectives, the specific technical uncertainties encountered, the systematic process of experimentation used to resolve those uncertainties (including alternatives considered and trials performed), and technical progress reports.15 This process substantiates the technical validity of the claim, proving that the Four-Part Test was met and preventing the rejection of QREs on the grounds that the activity was routine or non-technological.

Action Item 2: Personnel Time Tracking. Since qualified wages often form the largest component of QREs, companies must require detailed, contemporaneous time tracking, preferably daily or weekly. This tracking must accurately link employee effort to specific qualified research projects and distinguish technical R&D time from general overhead, management, or administrative time.15 Such detailed records provide the necessary financial substantiation for the claimed wages, defending against challenges related to the “direct supervision/support” rules and the exclusion of G&A costs.

5.2. Navigating Post-TCJA Financial Strategy (The §174/§41 Interface)

The complexity introduced by the $\S$174 capitalization rules demands sophisticated financial planning to optimize cash flow and minimize unintended tax consequences.

Action Item 3: Modeling §174A Transition. Businesses must thoroughly model the financial impact of the potential restoration of domestic R&E expensing (beginning in 2025 under $\S$174A). This modeling must compare the benefit of immediate deduction of 2025 R&E costs against the option to accelerate the recovery of costs capitalized during the 2022–2024 period versus continuing the amortization schedule.12 Modeling is crucial to ensure optimal timing of deductions and protect against technical pitfalls, such as unintentionally meeting the definition of a tax shelter under $\S$448(c) due to large, one-time deductions.12

Action Item 4: Continuous Cost Allocation Review. Integration between R&D project management and financial reporting systems must be maintained to ensure absolute accuracy in cost allocation. This includes verifying that supply costs are correctly identified as non-depreciable QREs versus depreciable capital costs, and that all contract structures adhere to the rigorous requirements regarding economic risk and retention of substantial rights necessary to avoid the funded research exclusion.5 Preventing the commingling of ineligible costs (such as G&A or capitalized assets) with QREs remains a paramount goal, as it is a major area for IRS audit adjustments.

5.3. Mastering IRS Form 6765 Compliance

The final submission document, Form 6765, Credit for Increasing Research Activities, must accurately reflect the complex calculations performed and the supporting documentation compiled.

Action Item 5: Structured Filing. Ensure meticulous and accurate completion of all required sections of Form 6765, whether electing the Regular Credit (Section A) or the Alternative Simplified Credit (Section B).1 If a Qualified Small Business election is made, Section D must be fully and accurately completed to apply the credit against payroll tax liability.19 Accuracy on this form is paramount, as computational errors or incomplete sections can immediately trigger IRS audit scrutiny, regardless of the quality of the underlying technical documentation.

The implementation of these measures transforms the documentation requirement into an ongoing, integrated process supported by a contemporaneous “paper trail” that demonstrates legitimate research activities, thereby maximizing the defensibility of claimed QREs and securing the intended financial benefits.

Contemporaneous Documentation Checklist for Audit Defense

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/